2,200 Is Minimum Number of Daily Steps Needed to Lower Death, CVD Risk
By Lori Solomon HealthDay Reporter
FRIDAY, March 15, 2024 -- Any amount of activity above 2,200 steps per day is associated with lower mortality and cardiovascular disease (CVD) risk, regardless of sedentary time, according to a study published online March 5 in the British Journal of Sports Medicine.
Matthew N. Ahmadi, from University of Sydney, and colleagues examined associations between daily step count and all-cause mortality and incident CVD by sedentary time levels. Analysis included data from 72,174 older participants in the U.K. Biobank followed for 6.9 years.
The researchers found that compared to a reference of 2,200 steps/day (fifth percentile), the optimal dose (nadir of the curve) for all-cause mortality ranged between 9,000 and 10,500 steps/day for high (hazard ratio [HR], 0.61) and low (HR, 0.69) sedentary time. There was a subtle gradient of association by sedentary time level with the lowest risk of incident CVD observed at approximately 9,700 steps/day for high (HR, 0.79) and low (HR, 0.71) sedentary time. Across sedentary time groups, the minimal dose (steps/day associated with 50 percent of the optimal dose) of daily steps was between 4,000 and 4,500 steps/day for all-cause mortality and incident CVD.
"For a roughly equivalent number of steps/day, the risk of incident CVD was lower for low sedentary time compared with high sedentary time," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted March 2024
Read this next
Semaglutide Cuts Risk for Kidney Outcomes, Death in CKD With T2DM
FRIDAY, May 31, 2024 -- For patients with type 2 diabetes and chronic kidney disease, semaglutide reduces the risk for clinically important kidney outcomes and death from...
DNA Methylation-Based Epigenetic Age Mediates Link Between LE8 Score, CVD
WEDNESDAY, May 29, 2024 -- The associations between Life's Essential 8 (LE8) and cardiovascular health are mediated by DNA methylation-based epigenetic age, according to a study...
Semaglutide Boosts Kidney Outcomes With Obesity + Cardiovascular Disease
TUESDAY, May 28, 2024 -- Once-weekly subcutaneous semaglutide shows a benefit for kidney outcomes in people with overweight or obesity and established cardiovascular disease...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.